Merlin D - Search Results

1

Liu D, Saikam V, Skrada KA, Merlin D, Iyer SS. Liu D, et al. Among authors: merlin d. Med Res Rev. 2022 Sep;42(5):1856-1887. doi: 10.1002/med.21893. Epub 2022 May 23. Med Res Rev. 2022. PMID: 35603998 Free PMC article. Review.

2

Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules.

Merlin D, Si-Tahar M, Sitaraman SV, Eastburn K, Williams I, Liu X, Hediger MA, Madara JL. Merlin D, et al. Gastroenterology. 2001 Jun;120(7):1666-79. doi: 10.1053/gast.2001.24845. Gastroenterology. 2001. PMID: 11375948

3

The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease.

Ingersoll SA, Ayyadurai S, Charania MA, Laroui H, Yan Y, Merlin D. Ingersoll SA, et al. Among authors: merlin d. Am J Physiol Gastrointest Liver Physiol. 2012 Mar 1;302(5):G484-92. doi: 10.1152/ajpgi.00477.2011. Epub 2011 Dec 22. Am J Physiol Gastrointest Liver Physiol. 2012. PMID: 22194420 Free PMC article. Review.

4

Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease.

Xiao B, Merlin D. Xiao B, et al. Among authors: merlin d. Expert Opin Drug Deliv. 2012 Nov;9(11):1393-407. doi: 10.1517/17425247.2012.730517. Epub 2012 Oct 5. Expert Opin Drug Deliv. 2012. PMID: 23036075 Review.

5

Longitudinal study of circulating protein biomarkers in inflammatory bowel disease.

Viennois E, Baker MT, Xiao B, Wang L, Laroui H, Merlin D. Viennois E, et al. Among authors: merlin d. J Proteomics. 2015 Jan 1;112:166-79. doi: 10.1016/j.jprot.2014.09.002. Epub 2014 Sep 16. J Proteomics. 2015. PMID: 25230104 Free PMC article.

6

Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine.

Viennois E, Zhao Y, Merlin D. Viennois E, et al. Among authors: merlin d. Inflamm Bowel Dis. 2015 Oct;21(10):2467-74. doi: 10.1097/MIB.0000000000000444. Inflamm Bowel Dis. 2015. PMID: 25985250 Free PMC article. Review.

7

Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.

Zhang M, Viennois E, Prasad M, Zhang Y, Wang L, Zhang Z, Han MK, Xiao B, Xu C, Srinivasan S, Merlin D. Zhang M, et al. Among authors: merlin d. Biomaterials. 2016 Sep;101:321-40. doi: 10.1016/j.biomaterials.2016.06.018. Epub 2016 Jun 9. Biomaterials. 2016. PMID: 27318094 Free PMC article.

8

Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases?

Zhang M, Collins JF, Merlin D. Zhang M, et al. Among authors: merlin d. Nanomedicine (Lond). 2016 Dec;11(23):3035-3037. doi: 10.2217/nnm-2016-0353. Epub 2016 Nov 4. Nanomedicine (Lond). 2016. PMID: 27813445 Free PMC article. No abstract available.

9

Nanotherapeutics for the treatment of inflammatory bowel disease.

Chen Q, Xiao B, Merlin D. Chen Q, et al. Among authors: merlin d. Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):495-497. doi: 10.1080/17474124.2017.1309282. Epub 2017 Mar 24. Expert Rev Gastroenterol Hepatol. 2017. PMID: 28317404 No abstract available.

10

Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans.

Viennois E, Zhao Y, Han MK, Xiao B, Zhang M, Prasad M, Wang L, Merlin D. Viennois E, et al. Among authors: merlin d. Sci Rep. 2017 May 31;7(1):2520. doi: 10.1038/s41598-017-02782-1. Sci Rep. 2017. PMID: 28566745 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

229 results

Search Page